| 06/08/2026 5:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/28/2026 5:06 AM | Sanofi (1121404) Filer | Form SD Specialized Disclosure Report | |
| 05/27/2026 9:31 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/07/2026 7:47 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 05/06/2026 5:00 AM | Agomab Therapeutics NV (2020932) Subject Sanofi (1121404) Filed by | Form SCHEDULE 13G | |
| 05/05/2026 5:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/29/2026 5:04 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/27/2026 11:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2026 6:20 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2026 5:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/10/2026 8:58 AM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
$36 million a day says something big is coming (Ad) Institutional capital is flowing into one thesis at a rate of $36 million per day - $25,000 every single minute. Morgan Stanley puts the addressable market at $5 trillion, and the smart money is already positioned.
Pentagon-funded research from Rensselaer Polytechnic Institute identified a precise tipping point: once roughly 10% of a population adopts a new idea, the rest of the system flips fast. That threshold was just crossed. Porter Stansberry, with nearly 30 years in the markets, says this opportunity is bigger than dot-com, crypto, and the 2023 AI rally combined. See where the institutional money is flowing before the window closes |
| 03/31/2026 11:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/24/2026 10:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/10/2026 9:40 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/04/2026 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/03/2026 5:15 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/23/2026 8:19 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 12:28 PM | Sanofi (1121404) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/17/2026 11:34 AM | Sanofi (1121404) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 02/17/2026 11:44 AM | Sanofi (1121404) Filer | Form IRANNOTICE | |
| 02/17/2026 8:33 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/12/2026 8:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/11/2026 7:47 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 02/10/2026 8:18 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/10/2026 5:06 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 02/06/2026 9:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/05/2026 5:17 AM | Sanofi (1121404) Filer | Form S-8 POS | |
| 01/30/2026 6:55 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/29/2026 7:56 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/28/2026 5:37 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 01/23/2026 8:58 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/16/2026 5:02 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/12/2026 5:11 AM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-T | |
| 01/09/2026 5:09 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:42 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 3:44 PM | DYNAVAX TECHNOLOGIES CORP (1029142) Subject Sanofi (1121404) Filed by | Form SC TO-C | |
| 12/29/2025 5:22 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 5:23 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/23/2025 8:52 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/22/2025 11:25 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/15/2025 9:17 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Tiny Nasdaq Firm Lands €13.9 Million Semiconductor Deal (Ad) One small Nasdaq-listed company just landed a 13.9 million euro contract tied to a new advanced-node semiconductor facility in Europe - weeks after closing a separate $3 million deal in Arizona's semiconductor corridor.
The company has participated in more than 1,000 semiconductor fab projects across North America, Europe, and Asia, yet most investors haven't heard of it. As the AI chip buildout accelerates, this under-the-radar name sits deep inside the supply chain making it all possible. Get the full breakdown on this overlooked semiconductor supply chain play |
| 12/12/2025 11:26 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/03/2025 10:30 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 11:29 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/14/2025 4:34 PM | Amundi (1330387) Filed by Sanofi (1121404) Subject | Form SCHEDULE 13G/A | |
| 11/04/2025 9:51 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 11/03/2025 10:40 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/31/2025 12:48 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/29/2025 10:15 AM | Sanofi (1121404) Filer | Form 424B5 | |
| 10/28/2025 9:57 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/27/2025 8:12 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:13 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:15 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:17 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 8:20 PM | Sanofi (1121404) Subject | Form FWP | |
| 10/27/2025 7:32 AM | Sanofi (1121404) Filer | Form 424B5 | |
| 10/27/2025 6:56 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/24/2025 5:20 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/24/2025 5:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/15/2025 11:07 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/26/2025 8:41 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/22/2025 1:59 PM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/17/2025 11:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/04/2025 11:55 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/03/2025 11:44 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/29/2025 9:36 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/31/2025 10:33 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/31/2025 7:06 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/31/2025 6:34 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/30/2025 7:09 AM | Sanofi (1121404) Filer | Form N-PX Annual Report of Proxy Voting Record of Registered Management Investment Company | |
| 07/29/2025 11:18 AM | Sanofi (1121404) Filer | Form 13F-HR Initial Quarterly Form 13F Holdings report filed by institutional managers | |
| 07/22/2025 7:49 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/18/2025 5:03 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/17/2025 5:04 AM | Blueprint Medicines Corp (1597264) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 07/10/2025 5:04 AM | Blueprint Medicines Corp (1597264) Subject Sanofi (1121404) Filed by | Form SC TO-T/A | |
| 07/02/2025 7:25 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/27/2025 3:49 PM | Sanofi (1121404) Filer | Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
| 06/24/2025 7:31 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/18/2025 5:43 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/17/2025 7:33 AM | Sanofi (1121404) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/17/2025 5:07 AM | Blueprint Medicines Corp (1597264) Subject Sanofi (1121404) Filed by | Form SC TO-T | |